Pharmacology of inhaled glucocorticoids. Comparative properties

Immunology and Allergy Clinics of North America

Volumn 19, Issue 4, 1999, Pages 725-738

  Kelly, H W ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; BECLOMETASONE; BUDESONIDE; FLUNISOLIDE; FLUTICASONE; GLUCOCORTICOID; LIVER ENZYME; TRIAMCINOLONE; TYROSINE AMINOTRANSFERASE;

ARTICLE; ASTHMA; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; DRUG POTENCY; DRUG SAFETY; ENZYME ACTIVITY; FIRST PASS EFFECT; HUMAN; INHALATIONAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0032711195     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8561(05)70119-3     Document Type: Article

References (59)

1. L. Agertoft S. Pedersen Importance of the inhalation device on the effect of budesonide Arch Dis Child 69 1993 130 133
2. L. Agertoft S. Pedersen A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler J Allergy Clin Immunol 99 1997 773 780
3. R. Ahrens C. Lux Bahl T. Han S.-H. Choosing the metered-dose inhaler spacer or holding chamber that matches the patient's need: Evidence that the specific drug being delivered is an important consideration J Allergy Clin Immunol 96 1995 288 294
4. J.G. Ayres E.D. Bateman B. Lundbäck High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma Eur Respir J 8 1995 579 586
5. N.C. Barnes G. Marone Di Maria G.U. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma Eur Respir J 6 1993 877 884
6. N.C. Barnes C. Hallett T.A.J. Harris Clinical experience with fluticasone propionate in asthma: A meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less Respir Med 92 1998 95 104
7. P.J. Barnes S. Pedersen W.W. Busse Efficacy and safety of inhaled corticosteroids: New developments Am J Respir Crit Care Med 157 suppl 1998 S1 S53
8. P.W. Barry C. O'Callaghan Nebuliser therapy in childhood Thorax 52 suppl 2 1997 S78 S88
9. J.S. Berg J. Dischler D.J. Wagner Patient compliance Ann Pharmacother 27 1993 S5 S19
10. H. Bisgaard Delivery of inhaled medication to children J Asthma 34 1997 443 467
11. J. Boe P. Bakke T. Rødølen High-dose inhaled steroids in asthmatics: Moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis Eur Respir J 7 1994 2179 2184
12. G.B. Bootsma P.N.R. Dekhuijzen J. Festen Fluticasone propionate does not influence bone metabolism in contrast to beclomethasone dipropionate Am J Respir Crit Care Med 153 1996 924 230
13. F.D. Boudinot R. D'Ambrosio W.J. Jusko Receptor-mediated pharmacodynamics of prednisolone in the rat J Pharmacokinet Biopharm 14 1986 469 493
14. R. Brattsand What factors determine anti-inflammatory activity and selectivity of inhaled steroids? European Respiratory Review 7 1997 356 361
15. P.H. Brown G. Blundell A.P. Greening Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids? Thorax 45 1990 736 739
16. Chervinsky P. van As A. E.A. Bronsky Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma J Allergy Clin Immunol 94 1994 676 683
17. J. Condemi P. Chervinsky M. Goldstein Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma J Allergy Clin Immunol 100 1997 467 474
18. R. Dahl B. Lundback Malo J.-L. A dose-ranging study of fluticasone propionate in adult patients with moderate asthma Chest 104 1993 1352 1358
19. B. Davies A comparison of beclomethasone dipropionate and budesonide in the treatment of asthma British Journal of Clinical Practice 47 1993 87 93
20. H. Derendorf Pharmacokinetic and pharmacodynamic properties of inhaled corticosteroids in relation to efficacy and safety Respir Med 91 suppl A 1997 22 28
21. H. Derendorf G. Hochhaus H. Mollmann Receptor-based pharmacokinetic-pharmacodynamic analysis of corticosteroids Journal of Pharmacology 33 1993 115 123
22. S.G. Devadason M.L. Everard C. MacEarlan Lung deposition from the Turbuhaler® in children with cystic fibrosis Eur Respir J 10 1997 2023 2028
23. P. Ebden A. Jenkins G. Houston Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500 g/day) and budesonide (1600 g/day), for chronic asthma Thorax 41 1986 869 874
24. L. Fabbri P.S. Burge L. Croonenborgh Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year Thorax 48 1993 817 823
25. V. Gemou-Engesaeth A. Bush A.B. Kay Inhaled glucocorticoid therapy of childhood asthma is associated with reduced peripheral blood T cell activation and `Th2-type' cytokine mRNA expression Pediatrics 99 1997 695 703
26. R.J. Gonzales-Rothi S. Suarez G. Hochhaus Pulmonary targeting of liposomal triamcinolone acetonide phosphate Pharm Res 13 1996 1699 1703
27. A. Grahnen S.A. Eckernas R.M. Brundin An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers Br J Clin Pharmacol 38 1994 521 525
28. P. Gustafsson J. Tsanakas M. Gold Comparison of the efficacy and safety of inhaled fluticasone propionate 200 μg/day with inhaled beclomethasone dipropionate 400 μg/day in mild and moderate asthma Arch Dis Child 69 1993 206 211
29. 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma N Engl J Med 325 1991 388 392
30. L.S. Hill A.L. Slater A comparison of the performance of two modern multidose dry powder asthma inhalers Respir Med 92 1998 105 110
31. G. Hochhaus R.J. Gonzales-Rothi A. Lukyanov Assessment of glucocorticoid lung targeting by ex vivo receptor binding studies Pharm Res 12 1995 134 137
32. G. Hochhaus H. Mollmann H. Derendorf Pharmacokinetic/pharmacodynamic aspects of aerosol therapy using glucocorticoids as a model J Clin Pharmacol 37 1997 881 892
33. J.C.M. Hoekx G. Hedlin W. Pedersen Fluticasone propionate compared with budesonide: A double-blind trial in asthmatic children using powder devices at a dosage of 400 μg/day Eur Respir J 9 1996 2263 2272
34. P. Hogger P. Rohdewald Binding kinetics of fluticasone propionate to the human glucocorticoid receptor Steroids 59 1994 597 602
35. W.J. Jusko Corticosteroid pharmacodynamics: Models for a broad array of receptor-mediated pharmacologic effects J Clin Pharmacol 30 1990 303 310
36. A. Kamada S.J. Szefler R.J. Martin Issues in the use of inhaled glucocorticoids Am J Respir Crit Care Med 153 1996 1739 1748
37. H.W. Kelly Comparison of inhaled corticosteroids Ann Pharmacother 32 1998 220 232
38. H.A. Kerstjens P.L.P. Brand de Jong P.M. Influence of treatment on peak expiratory flow and its relation to airway hyperresponsiveness and symptoms Thorax 49 1994 1109 1115
39. S.A. Kharitonov D.H. Yates K.F. Chung Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients Eur Respir J 9 1996 196 201
40. P. Leblanc S. Mink T. Keistinen A comparison of fluticasone propionate 200 μg/day with beclomethasone dipropionate 400 μg/day in adult asthma Allergy 49 1994 380 385
41. B.J. Lipworth Airway and systemic effects of inhaled corticosteroids in asthma: Dose-response relationship Pulmonary Pharmacology 9 1996 19 27
42. −1) administered by pressurized inhaler Respir Med 87 1993 609 620
43. R.A. Nathan K.B. Nolop F.M. Cuss A comparison of double-strength beclomethasone dipropionate (84 μg) MDI with beclomethasone dipropionate (42 μg) MDI in the treatment of asthma Chest 112 1997 34 39
44. National Asthma Education and Prevention Program Guidelines for the diagnosis and management of asthma. Expert Panel Report 2 1997 US Dept of Health and Human Services Bethesda, MD Publication 97-4051
45. R. Pauwels S. Newman L. Borgstrom Airway deposition and airway effects of antiasthma drugs delivered from metered-dose inhalers Eur Respir J 10 1997 2127 2138
46. R.A. Pauwels M.G. Demedts J.C. Yernault Comparison of long-term safety and efficacy of fluticasone propionate and beclomethasone dipropionate in combination with salmeterol in patients with moderate to severe asthma [abstract] Am J Respir Crit Care Med 151 1995 A276
47. S. Pedersen O.R. Hansen Budesonide treatment of moderate and severe asthma in children: A dose-response study J Allergy Clin Immunol 95 1995 29 33
48. S. Pedersen P. O'Byrne A comparison of the efficacy and safety of inhaled corticosteroids in asthma Allergy 52 suppl 39 1997 1 34
49. E. Pizzichini M.M.M. Pizzichini A. Efthimiadis Measuring airway inflammation in asthma: Eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood J Allergy Clin Immunol 99 1997 539 544
50. N. Ringdahl P. Swinburn R. Backman A blinded comparison of fluticasone propionate with budesonide via powder devices in adult patients with moderate-to-severe asthma: A clinical evaluation Mediators of Inflammation 5 1996 382 389
51. J.D. Spahn D.Y.M. Leung W. Surs Reduced glucocorticoid binding affinity in asthma is related to ongoing allergic inflammation Am J Respir Crit Care Med 151 1995 1709 1714
52. S.H. Srebro P.R. Rogenes L. Edwards Comparison of efficacy and HPA effects of fluticasone propionate versus flunisolide in patients with mild to moderate asthma Am J Respir Crit Care Med 157 1998 A406
53. U.G. Svendsen L. Frølund J.H. Heinig High-dose inhaled steroids in the management of asthma: A comparison of the effects of budesonide and beclomethasone dipropionate on pulmonary function, symptoms, bronchial responsiveness and the adrenal function Allergy 47 1992 174 180
54. L. Thorsson Influence of inhaler systems on systemic availability, with focus on inhaled corticosteroids Journal of Aerosol Medicine 8 suppl 3 1995 S29 S36
55. J.H. Toogood P. Andreou J. Baskerville A methodological assessment of diurnal variability of peak flow as a basis for comparing different inhaled steroid formulations J Allergy Clin Immunol 98 1996 555 562
56. J.H. Toogood F.A. White J.C. Baskerville Comparison of the antiasthmatic oropharyngeal, and systemic glucocorticoid effects of budesonide administered through a pressurized aerosol plus spacer or the Turbuhaler dry powder inhaler J Clin Allergy Immunol 99 1997 186 193
57. J.H. Toogood Side effects of inhaled corticosteroids J Allergy Clin Immunol 102 1998 705 713
58. P. Venge Soluble markers of allergic inflammation Allergy 49 1994 1 8
59. R.F. Willey D.J. Godden J. Carmichael Comparison of twice daily administration of a new corticosteroid budesonide with beclomethasone dipropionate four times daily in the treatment of chronic asthma Br J Dis Chest 76 1982 61 68